Article Details

Korea's Lotte plans to scale its biologics CDMO business in North America as it buys BMS site

Retrieved on: 2022-05-17 16:35:38

Tags for this article:

Click the tags to see associated articles and topics

Korea's Lotte plans to scale its biologics CDMO business in North America as it buys BMS site. View article details on hiswai:

Excerpt

Over time, the Korean firm will use the facility to expand its CDMO offerings for the biopharma industry. Hunki Lee, EVP of Lotte Corporation, ...

Article found on: www.biopharma-reporter.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up